This site uses essential and third-party cookies to gather usage and satisfaction stats. By browsing, you agree to their use.

Spin-off companies

Established in 2009 as IMEGEN, now part of Health In Code

Established in 2019

Translational Pharma Solutions

Aiming to repurpose haloperidol as a treatment for Spinal Muscular Atrophy (SMA) patients, under the leadership of Irene González Martínez

Pre-Launch Venture Capital Opportunity

Aiming to develop gapmers as innovative drugs for biomedical indications

Pre-Launch Venture Capital Opportunity

Page updated

Google Sites

Report abuse